Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

543 ARTÍCULOS , VIENDO DEL 466 AL 480

Basic Scientific Evidence Consistent with Etanercept Efficacy Against Alzheimer's Disease

Clark I.

Neuroscience. 2022 Feb 21;484:139. doi: 10.1016/j.neuroscience.2021.11.002. Epub 2021 Dec 22.

Multicenter randomized controlled trial of the effects of individual reminiscence therapy on cognition, depression and quality of life: Analysis of a sample of older adults with Alzheimer's disease and vascular dementia

Pérez-Sáez E, Justo-Henriques SI, Alves Apóstolo JL.

Clin Neuropsychol. 2022 Oct;36(7):1975-1996. doi: 10.1080/13854046.2021.1871962. Epub 2021 Jan 19.

Utilization of Specialized Geriatric Care Among Medicare Beneficiaries with Alzheimer's Disease and Related Dementia: An Observational Analysis

Nikpay S, Keohane LM, Cheng A, Braun K, Buntin M, Lipworth L, Stevenson D.

J Gen Intern Med. 2022 Feb;37(2):469-471. doi: 10.1007/s11606-020-06460-3. Epub 2021 Jan 22.

Neuropsychological, neuropsychiatric, and quality-of-life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study

Boada M, López OL, Olazarán J, Núñez L, Pfeffer M, Puente O, Piñol-Ripoll G, Gámez JE, Anaya F, Kiprov D, Alegret M, Grifols C, Barceló M, Bozzo J, Szczepiorkowski ZM, Páez A; AMBAR Trial Group.

Alzheimers Dement. 2022 Jul;18(7):1314-1324. doi: 10.1002/alz.12477. Epub 2021 Nov 2.

The efficacy of psychological interventions for depressed primary caregivers of patients with Alzheimer's disease: A systematic review and meta-analysis

Liu X, Wang Y, Wang S.

J Nurs Scholarsh. 2022 May;54(3):355-366. doi: 10.1111/jnu.12742. Epub 2021 Nov 29.

Self-efficacy in controlling upsetting thoughts, but not positive gains, mediates the effects of benefit-finding group intervention for Alzheimer family caregivers

Cheng ST, Chan WC, Fung HH, Lam LCW.

Psychol Aging. 2022 Sep;37(6):766-775. doi: 10.1037/pag0000654. Epub 2021 Nov 29.

Decisional capacity to consent to treatment and research in patients affected by Mild Cognitive Impairment. A systematic review and meta-analysis

Parmigiani G, Del Casale A, Mandarelli G, Barchielli B, Kotzalidis GD, D'Antonio F, Di Vita A, de Lena C, Ferracuti S.

Int Psychogeriatr. 2022 Jun;34(6):529-542. doi: 10.1017/S1041610220004056. Epub 2021 Feb 15.

Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical Trial

Devanand DP, Crocco E, Forester BP, Husain MM, Lee S, Vahia IV, Andrews H, Simon-Pearson L, Imran N, Luca L, Huey ED, Deliyannides DA, Pelton GH.

Am J Geriatr Psychiatry. 2022 Jan;30(1):32-42. doi: 10.1016/j.jagp.2021.04.014. Epub 2021 May 12.

Dietary and supplemental long-chain omega-3 fatty acids as moderators of cognitive impairment and Alzheimer's disease

Wood AHR, Chappell HF, Zulyniak MA.

Eur J Nutr. 2022 Mar;61(2):589-604. doi: 10.1007/s00394-021-02655-4. Epub 2021 Aug 15.

Novel insights into RIPK1 as a promising target for future Alzheimer's disease treatment

Li S, Qu L, Wang X, Kong L.

Pharmacol Ther. 2022 Mar;231:107979. doi: 10.1016/j.pharmthera.2021.107979. Epub 2021 Sep 2.

Is resveratrol a prospective therapeutic strategy in the co-association of glucose metabolism disorders and neurodegenerative diseases?

Ribeiro R, Santos AC, Calazans MO, De Oliveira ACP, Vieira LB.

Nutr Neurosci. 2022 Nov;25(11):2442-2457. doi: 10.1080/1028415X.2021.1972514. Epub 2021 Sep 11.

The cerebral changes induced by exercise interventions in people with mild cognitive impairment and Alzheimer's disease: A systematic review

Huang X, Zhao X, Cai Y, Wan Q.

Arch Gerontol Geriatr. 2022 Jan-Feb;98:104547. doi: 10.1016/j.archger.2021.104547. Epub 2021 Oct 3.

Evaluation of memory performance in patients with brain disorders following rTMS treatment. A systematic review

Bonotis K, Anargyros K, Liaskopoulos N, Barlogianni AM.

Clin Neurophysiol. 2022 Mar;135:126-153. doi: 10.1016/j.clinph.2021.11.078. Epub 2021 Dec 24.

The clinical correlation of proinflammatory and anti-inflammatory biomarkers with Alzheimer disease: a meta-analysis

Anuradha U, Kumar A, Singh RK.

Neurol Sci. 2022 Jan;43(1):285-298. doi: 10.1007/s10072-021-05343-7. Epub 2021 May 25.

Apathy as a Treatment Target in Alzheimer's Disease: Implications for Clinical Trials

Mortby ME, Adler L, Agüera-Ortiz L, Bateman DR, Brodaty H, Cantillon M, Geda YE, Ismail Z, Lanctôt KL, Marshall GA, Padala PR, Politis A, Rosenberg PB, Siarkos K, Sultzer DL, Theleritis C; ISTAART NPS PIA.

Am J Geriatr Psychiatry. 2022 Feb;30(2):119-147. doi: 10.1016/j.jagp.2021.06.016. Epub 2021 Jul 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias